Dyslipidemia with altered oxidant-antioxidant status in rheumatoid arthritis

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 1, 2011, Pages 424-428

  Kowsalya, R ^a   Sreekantha, ^b   Chandran, Vinod ^b   Remya, ^c  

^a Institute of Nephrourology   (India)

^b MANIPAL UNIVERSITY   (India)

^c NITTE UNIVERSITY   (India)

Author keywords

Antioxidants; Dyslipidemia; Lipid peroxidation; Rheumatoid arthritis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZING AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; RHEUMATOID ARTHRITIS; VITAMIN BLOOD LEVEL;

EID: 84855303540     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Biji T, Kurien and R Hal Scofield. Autoimmunity and oxidatively modified autoantigens, Autoimmun Rev,7:567-573,(2008).
2. Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis, Circulation 100: 2124- 2126,(1999).
3. Myllykangas-Lousujarvi R, Aho K, Kautianen H, Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis, J Rheumatol,222:1065-1067, (1995).
4. Lazarevic MB, Vilic J, Mladenovic V, Myones BL, SkoseyJL, Swendler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis, Semin Arthritis Rheum,22:172-180,(1992).
5. Mahajan A, Tandon VR. Antioxidants and rheumatoid arthritis, J Indian Rheumatol Assoc, 12:139-142,(2004).
6. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis, JAMA,284: 984-992,(2000).
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31: 315-324,(1988).
8. Stocks J, Dormandy TL. The auto oxidation of human red cells lipid reduced by hydrogen peroxide, Brit J Hematol,20: 95-111,(1971).
9. Baker and Frank. Determination of serum tocopherol by colorimetric method, In: Varley's practical clinical biochemistry, Heinmann Professional Publishing,6thEdition.902,(1988).
10. Tietz, N.W. In: Text book of clinical chemistry. 3rd edition. W.B. Saunders Company, Philadelphia. 900-902,(1986).
11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 340:115-126,(1999).
12. McCord JM. The evolution of free radicals and oxidative stress, Am J Med, 108:652-659,(2000).
13. V Chaturvedi, R Handa, D N Rao and J P Wari. Estimation and significance of serum and synovail fluid malondialdehyde levels in rheumatoid arthritis, Ind J Med Res109: 170-174,(1999).
14. Gutteridge J M. Antioxidant properties of the proteins ceruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis, Biochem Biophys acta,869(2):119-127,(1986).
15. Padayatti SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vitamin C as an antioxidant: Evaluation of its role in disease prevention, J Am College of Nutr,22 (1):18-35,(2003).
16. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-278.
17. Edmonds SE, Winyard PG, Guo R et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial, Ann Rheum Dis, 56:649- 655,(1997).
18. Lakatos J, Harsagyi A. Serum total HDL, LDL cholesterol and triglycerides in active rheumatoid arthritis, Clin biochem, 21:93-96,(1988).
19. Ledwozym A, Michalak J, Stepien A, Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis, Clin ChemActa,155: 275-284,(1986).